Mitesco, Inc.
For the period ended Dec 31, 2024. Filed Mar 31, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 31, 2025
MITIStored price and day change unavailable
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
CONSOLIDATED BALANCE SHEETS
| December 31, | December 31, | |
|---|---|---|
| 2024 | 2023 | |
| ASSETS | ||
| Current assets | ||
| Cash and cash equivalents | $3,402 | $2,838 |
| Accounts receivable | 29,700 | - |
| Prepaid expenses and other current assets | 4,968 | - |
| Total current assets | 38,070 | 2,838 |
| Intangible assets, net | 151,771 | - |
| Total Assets | $189,841 | $2,838 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) | ||
| Current liabilities | ||
| Accounts payable and accrued liabilities | $4,167,061 | $7,838,112 |
| Accrued interest | 374,376 | 348,821 |
| Accrued interest - related parties | 22,547 | 61,792 |
| Derivative liabilities | 4,685,675 | 152,945 |
| Royalty payable | 150,000 | - |
| Lease liability - operating leases, current | 99,477 | 99,477 |
| Notes payable, net of discounts | 548,137 | 945,429 |
| Notes payable - related parties, net of discounts | 64,044 | 300,012 |
| SBA loan payable | 393,761 | 421,788 |
| Other current liabilities | 96,136 | 121,136 |
| Preferred stock dividends payable | - | 1,551,833 |
| Preferred stock dividends payable - related parties | 14,439 | 73,364 |
| Legal settlements | 2,666,675 | 2,219,886 |
| Series A preferred stock liability, current | 5,160,815 | - |
| Total current liabilities | 18,443,143 | 14,134,595 |
| Series A preferred stock liability, non-current | 8,162,644 | - |
| Total liabilities | 26,605,787 | 14,134,595 |
| Commitments and contingencies (Note 17) | ||
| Stockholders’ equity (deficit) | ||
| Preferred stock, $0.01 par value, 100,000,000 shares authorized; 10,000,000 shares designated Series D; 10,000 shares designated as Series E; 140,000 shares designated as Series F; and 27,324 shares designated Series X: | ||
| Preferred stock, Series D, $0.01 par value, 25,000 and 250,000 shares issued and outstanding as of December 31, 2024, and 2023 | 250 | 2,500 |
| Preferred stock, Series E, $0.01 par value, no shares issued and outstanding as of December 31, 2024, and 2023 | - | - |
| Preferred stock, Series F, $0.01 par value, 0 and 20,057 shares issued and outstanding as of December 31, 2024, and 2023 | - | 201 |
| Preferred stock, Series X, $0.01 par value, 19,703 and 24,227 shares issued and outstanding at December 31, 2024, and 2023 | 197 | 242 |
| Common stock, $0.01 par value, 500,000,000 shares authorized, 9,762,258 and 5,567,957 shares issued and outstanding as of December 31, 2024, and 2023, respectively | 97,623 | 55,680 |
| Additional paid-in capital | 37,341,335 | 47,856,444 |
| Accumulated deficit | (63,855,351) | (62,046,824) |
| Total stockholders’ equity (deficit) | (26,415,946) | (14,131,757) |
| Total liabilities and stockholders’ equity (deficit) | $189,841 | $2,838 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.